Home › Funds › Blue Owl Capital Holdings LP › ELDN

Blue Owl Capital Holdings LP position in ELDN

ELEDON PHARMACEUTICALS INC · Health Care

Blue Owl Capital Holdings LP reported holding 200,000 shares of ELDN (ELEDON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$100K, representing 0.02% of its reported portfolio and ranking #47 among its reported holdings. Blue Owl Capital Holdings LP has disclosed ELDN holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)200.00K sh
Reported value held$100.00K
Portfolio Weight0.02%
First reportedQ4 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's ELDN position evolved

Blue Owl Capital Holdings LP first disclosed a stake in ELDN in Q4 2024 at 1,959,912 shares (US$8.1M). Across 8 filings, Blue Owl Capital Holdings LP increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 200,000 shares valued at US$100K. Notable position changes include a 27% trim in Q2 2025 (shares fell 4% over the following quarter), a 97% increase in Q4 2025 (shares rose 104% over the following quarter), a 86% trim in Q2 2026 (shares fell 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.96M $8.07M New
Q1 2025 1.82M $6.17M Reduce
Q2 2025 1.33M $3.60M Reduce
Q3 2025 979.91K $2.54M Reduce
Q4 2025 1.93M $2.91M Add
Q1 2026 1.42M $4.37M Reduce
Q2 2026 200.00K $285.00K Reduce
Q3 2026 200.00K $100.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELDN and 13F data

ELDN (ELEDON PHARMACEUTICALS INC) is a Health Care company. 39 other funds we track also report a position in ELDN — the largest reported positions include BVF INC/IL (US$24.8M), Defilade Capital Management, L.P. (US$13.9M), Catalio Capital Management, LP (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELDN

All ELDN fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held ELDN?

Blue Owl Capital Holdings LP has disclosed ELDN holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Blue Owl Capital Holdings LP's current position in ELDN?

As of Q3 2026, Blue Owl Capital Holdings LP holds 200.00K shares of ELDN (ELEDON PHARMACEUTICALS INC), valued at $100.00K, representing 0.02% of its reported portfolio and ranking #47.

Has Blue Owl Capital Holdings LP been buying or selling ELDN?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP held unchanged its position in ELDN.

Which other funds hold ELDN?

Other major institutional holders of ELDN include BVF INC/IL, Defilade Capital Management, L.P., Catalio Capital Management, LP, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.